T. Takahara

A comparison of overall survival with 40 and 50mg/m2 pegylated liposomal doxorubicin treatment in patients with recurrent epithelial ovarian cancer: Propensity score-matched analysis of real-world data.

M. Nakayama, K. Fukushima, Hisanori Kobayashi, 2016, Gynecologic oncology.

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

M. Nakayama, K. Imanaka, Hisanori Kobayashi, 2016, BMC Urology.

Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer

M. Ando, J. Fujimoto, M. Nagino, 2018, The British journal of surgery.